Shares outstanding · 2017–2025
Pharming Group shares outstanding
702M+3.1% · FY2025
Pharming Group (PHAR) reported 702M in shares outstanding for fiscal 2025, +3.1% year on year.
| Fiscal year | Shares outstanding | Change | Filing |
|---|---|---|---|
| FY20252025-12-31 | 702M | +3.1% | Open → |
| FY20242024-12-31 | 680M | +1.4% | Open → |
| FY20232023-12-31 | 671M | +2.2% | Open → |
| FY20222022-12-31 | 656M | +1.2% | Open → |
| FY20212021-12-31 | 649M | +1.6% | Open → |
| FY20202020-12-31 | 639M | +1.2% | Open → |
| FY20192019-12-31 | 631M | +1.6% | Open → |
| FY20182018-12-31 | 622M | +7.3% | Open → |
| FY20172017-12-31 | 579M | — | Open → |
Shares outstanding — Shares outstanding is the number of shares in issue at the reporting date. A falling count usually means the company is buying back stock; a rising one means it is issuing.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2017–2025 compound annual growth +2.4%
Figures are reported under IFRS, in US dollars.
Shares outstanding at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Pharming Group shares outstanding |url=https://companiesranked.com/en/company/pharming-group/shares-outstanding |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Pharming Group shares outstanding. CompaniesRanked. https://companiesranked.com/en/company/pharming-group/shares-outstandingBibTeX
@misc{companiesranked-en-company-pharming-group-shares-outstanding-2026,
author = {{CompaniesRanked}},
title = {{Pharming Group shares outstanding}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/pharming-group/shares-outstanding}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 20-F · 0001828316-26-000015 · April 2, 2026
{{cite web |title=Pharming Group shares outstanding — 20-F (0001828316-26-000015) |url=https://www.sec.gov/Archives/edgar/data/1828316/000182831626000015/pharm-20251231.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-04-02}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.